BioSpace News Archive

SleepCharge Provides Businesses and Healthcare Systems Increased Resources to Support Population Sleep Health, More Additions in the Pipeline

While the majority of people said they agree an eye exam is important for overall health, many don’t know why and aren’t taking proactive measures to keep their eyes healthy

Kits Sent to Educators and Families Provide 11,000 Additional Youth Access to the STEM Education Activities

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced that it has expanded its pivotal Phase 3 REVERSE-IT trial for its lead product candidate bentracimab

Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation for TK216,

Company Locks-in Final Design Specifications, Begins Initial Build of Proprietary Ultra Shear Technology System, & Remains on Target for Commercial Release by Early 2021 [06-October-2020] SOUTH EASTON, Mass. , Oct. 6, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pr

Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces new data presented during the Heart Failure Society of America’s Annual Scientific Meeting focused on the use of Daxor’s BVA-100® blood test for uniquely measuring anemia.

Predictive Oncology (NASDAQ:POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is pleased to release the CEO’s letter to the shareholders.

Grey Cloak Tech Inc. (OTC: GRCK – name change pending to Healthy Extracts Inc.), today announces that its BergaMet NA subsidiary has introduced BergaMet Clinical IMMUNE™, a concentrated nutraceutical supplement formulated with naturally grown, heart-healthy Citrus Bergamot SuperFruit™, BetaVia™ Complete, and nine other powerful immune-boosting ingredients to create the No. 1 immune system defense for the body.

Patent Broadens Core Intellectual Property for the Intratumoral Delivery of Stimulatory Interleukins Using OncoSec’s Proprietary Electroporation (EP) Technology Platform